NTMT2 and colorectal carcinoma: METTL11B expression was higher in CRC tissues than in paraneoplastic tissues, and in CRC patients, progression-free survival and overall survival were significantly higher in the low METTL11B-expressing group than in the high METTL11B-expressing group, respectively (both P < 0.05).